Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
about
Role of the intestinal mucosa in acute gastrointestinal GVHD.Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.The Microbiota: A New Variable Impacting Cancer Treatment Outcomes.Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation.Tissue tolerance: a distinct concept to control acute GVHD severity.Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.Clinical Evidence for the Microbiome in Inflammatory Diseases.Microbial metabolites and graft versus host disease.Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD.Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection.Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation.Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?The Stool Microbiota at Neutrophil Recovery is Predictive for Severe Acute Graft versus Host Disease after Hematopoietic Cell Transplantation.Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype.Reduction of aGVHD using chicken antibodies directed against intestinal pathogens in a murine modelRepeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients.Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.Newly found arsons ignite the fire of gut GVHD.Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.Targeting RIG-I or STING promotes epithelial regeneration.New and emerging therapies for acute and chronic graft versus host disease.Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.Next-Generation Immune Repertoire Sequencing as a Clue to Elucidate the Landscape of Immune Modulation by Host-Gut Microbiome Interactions.The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.
P2860
Q36212428-89A86FEC-53F2-4005-96A1-DCA86F0C71FFQ36289007-A6789E2E-5224-499A-BAB0-6F48D0536FE7Q36308832-B7588CD9-7B80-4912-873A-4092BF9DB8EFQ37150434-1EDD90AE-A8F9-455B-B491-31CAB890A70BQ37672390-E6D66741-DF5F-47B5-BB7F-0D900354FC70Q37673349-787F3001-2ED9-4266-8C5E-CDC290968B32Q38743931-E9524ADF-6A7A-4709-8D26-99F8FA06D228Q38818111-F2198EC0-4111-4FA0-A83E-EE95B9D55A4CQ38924661-FBD2592F-1C49-4C22-9229-2479CDBC13B4Q39002164-09720217-D648-45F7-B69A-DD85E79704ECQ39035437-6C5DA52D-3F06-4625-8713-54C827C79612Q39035928-0E04F11A-8C6A-42E0-9E14-0A48D3C7E82DQ39116477-6B1BA3CD-42C7-4352-81D5-F562A3F6023DQ39180730-103C66FB-CC17-40DD-82CC-07488BA99A12Q39202357-E5EFF28F-B27D-4393-8123-9C28D3182230Q39247468-965E241E-66F0-48D1-85F1-7FAECF652AA7Q39265428-CC6B4BFB-7FF2-44F2-AD27-73EB8134C461Q39457656-8BBF28D7-8D90-44DD-8D67-949FE04D9E80Q40085896-8AE8251E-49BD-4DE6-9F86-1E7BDF6C87FDQ40129363-B2854CC2-9EBB-4348-B18C-1068D9D0F3E6Q40153463-FE665CA4-BE24-45FE-91C6-4F57062DB28CQ40258805-03829497-A171-4E27-A044-60C1F2C3EACCQ40333157-76B09B80-DD5B-4BEE-9997-EDF314CADE36Q41355730-75618E29-910B-4A89-88CD-F76CC3AEBBA9Q41987235-833ECAC9-1D9E-454B-BA98-1BDB366AE983Q41997024-F074A655-ACD4-401D-9932-371FB58CDC64Q42130752-25E324C3-5EFC-488A-A306-435C34FCA4F9Q42318634-A6D0E082-13A3-4723-9790-995236F91B54Q42336324-CA83A9CE-2124-426F-83EC-D747BC002386Q45875683-4674CAEE-8758-44B2-A003-6939CE15DA2BQ47608782-58949B84-57DD-414D-A489-BA31B7D8E7E5Q47673755-8257D31D-38EA-4AA6-B30B-BF64EDBF9978Q47742900-CAC632D8-6E38-44D8-8FBF-A806C3E410FBQ48260491-7BCA1F84-BE6C-4F9E-A0A9-BCA77B9FFBF3Q49182686-45EC3F39-7F00-4197-9FFB-35B6D743D799Q49238507-DD40620B-00CA-402D-A022-CC14B8076FD8Q49679320-3399C777-5F32-451A-952E-8E2B0B360AA1Q49806345-C6D9FE40-CF10-4198-9F1B-435BF87477F3Q52581846-6E542107-BC80-49B8-8FA5-8255FEBE331FQ52689883-8FC1C409-CA43-4403-9D28-AC7CCA4D32F6
P2860
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased GVHD-related mortali ...... on in human patients and mice.
@en
Increased GVHD-related mortali ...... on in human patients and mice.
@nl
type
label
Increased GVHD-related mortali ...... on in human patients and mice.
@en
Increased GVHD-related mortali ...... on in human patients and mice.
@nl
prefLabel
Increased GVHD-related mortali ...... on in human patients and mice.
@en
Increased GVHD-related mortali ...... on in human patients and mice.
@nl
P2093
P2860
P50
P1476
Increased GVHD-related mortali ...... on in human patients and mice.
@en
P2093
Alan M Hanash
Ami S Bhatt
Ann E Slingerland
Boglarka Gyurkocza
Camilla Gomes
Eli L Moss
Eric G Pamer
George F Murphy
Hendrik Poeck
P2860
P304
P356
10.1126/SCITRANSLMED.AAF2311
P407
P577
2016-05-01T00:00:00Z